Zurcher Kantonalbank (Zurich Cantonalbank) Harpoon Therapeutics, Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

  • $34.1 Billion
  • Q4 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 21, 2022
SELL
$3.54 - $8.08 $7,940 - $18,123
-2,243 Closed
0 $0
Q4 2021

Feb 01, 2022
SELL
$5.69 - $7.83 $1,325 - $1,824
-233 Reduced 9.41%
2,243 $17,000
Q3 2021

Nov 15, 2021
BUY
$7.88 - $14.0 $55 - $98
7 Added 0.28%
2,476 $20,000
Q2 2021

Jul 30, 2021
BUY
$13.81 - $23.25 $1,160 - $1,953
84 Added 3.52%
2,469 $34,000
Q1 2021

May 03, 2021
BUY
$17.65 - $24.16 $42,095 - $57,621
2,385 New
2,385 $50,000

Others Institutions Holding HARP

# of Institutions
2
Shares Held
353K
Call Options Held
0
Put Options Held
0
View Full List

About Harpoon Therapeutics, Inc.

HARP Quotes by TradingView
  • Ticker HARP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,106,800
  • Description
  • Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...
More about HARP
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email